Merit Medical (MMSI) Systems announced the US commercial release of the Prelude Wave Hydrophilic Sheath Introducer with SnapFix Securement Technology. The Prelude Wave is the latest innovation in Merit’s comprehensive Access portfolio, which includes a wide range of dilators, micro-access systems, sheath introducers, and guide sheaths. A low-profile, hydrophilic sheath with best-in-class insertion and sheath retention, the Prelude Wave with SnapFix technology is designed with features which may aid in the reduction of arterial spasm and occlusion as physicians perform radial access procedures.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MMSI:
- Merit Medical Systems: Strong Performance and Strategic Growth Drive Buy Rating Despite Reimbursement Challenges
- Merit Medical’s Earnings Call Highlights Robust Growth
- Merit Medical price target lowered to $103 from $112 at Baird
- Merit Medical price target lowered to $105 from $110 at Piper Sandler
- Merit Medical Systems: Strong Q2 Performance and Strategic Initiatives Justify Buy Rating